Women’s Health USA has been acquired by Unified Women’s Healthcare
|Deal Type||Mergers & Acquisitions|
|Client & Transactional Partners||
Women's Health USA
Sverica Capital Management
Unified Women's Healthcare
|Our Role||Sell-Side Advisor|
Cain Brothers served as exclusive financial advisor to Women’s Health USA, a portfolio company of Sverica Capital Management, on its sale to Unified Women’s Healthcare, a portfolio company of Altas Partners, Ares Management Corporation and Oak HC/FT. Together, Unified and WHUSA represent the largest physician practice management company dedicated solely to women in the United States. They will provide comprehensive business services to more than 2,500 providers across nearly 900 locations over North America. By helping providers focus on delivering the highest standards of care to ensure better patient outcomes, Unified and WHUSA will advance their vision for all women to have the best healthcare in the world.
Women’s Health USA is a provider of practice management and value-based care services to more than 600 women’s health providers in seven states. WHUSA is poised to play an influential role in developing new cost effective, value-based modes of care delivery. For 22 years, the company has successfully implemented innovative growth strategies and driven streamlined operational costs, payer alignment, ancillary services development, brand development strategies and risk management services.
Unified Women’s Healthcare is a diversified women’s health company focused on providing a better experience for patients, the people who care for them and the people and organizations who pay for that care. To support its vision of providing women with the best healthcare in the world, Unified has expanded its services platform to include reproductive healthcare services through its strategic partnership with CCRM Fertility, and the advancement of high-risk maternity care management services with its acquisition of Lucina. As a physician led company, Unified seeks innovative ways to preserve clinical autonomy, alleviate business and regulatory burdens, and empower physicians to make the greatest impact on transforming women’s healthcare for their patients.